Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

NCT02670577 is registered in ClinicalTrials.gov with Agendia as lead sponsor.

NCT NCT02670577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02670577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
Lead sponsor
Agendia
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
August 31, 2017
Enrollment
481 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer